Describes the biochemical design of carboxyalkanoyl and mercaptoalkanoyl amino acids as potent competitive inhibitors of angiotensin-converting enzyme.
This is the authors' abstract. We don't add key points for this paper.
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTDesign of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acidsD. W. Cushman, H. S. Cheung, E. F. Sabo, and M. A. OndettiCite this: Biochemistry 1977, 16, 25, 5484–5491Publication Date (Print):December 13, 1977Publication History Published online1 May 2002Published inissue 13 December 1977https://doi.org/10.1021/bi00644a014RIGHTS & PERMISSIONSArticle Views2361Altmetric-Citations721LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstract
Answers are grounded in this paper and cite their sources.
May guide preclinical ACE inhibitor design; leaves open clinical translation in cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Cushman et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: